RESTORE Study
RESTORE – A prospective Randomized Control Trial to compare the efficacy of the Revi System Therapy on versus off in relieving urinary urge incontinence episodes
- Sex: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Device
- Trial Phase: NA
- Conditions Being Studied:
Study Purpose
The purpose of this research study is to evaluate the effectiveness of the Revi System therapy in the treatment of urinary urge incontinence. Revi is a small FDA-approved device implanted near the ankle that stimulates the tibial nerve, which can help calm the bladder.
Who Can Participate
Individuals who suffer from symptoms of urgency incontinence alone or in combination with urinary urgency and are 18 years of age or older may meet the requirements for participation in this study.
Locations
UH Geauga Medical Center
13207 Ravenna Road
Chardon OH, 44024
UH Portage Medical Center
6847 North Chestnut Street
Ravenna Ohio, 44266
UH Ahuja Medical Center
3999 Richmond Road
Beachwood OH, 44122
UH Beachwood Medical Center
25501 Chagrin Blvd.
Beachwood OH, 44122
UH St. John Medical Center
29000 Center Ridge Road
Westlake OH, 44145
- UH IRB: SITE00002166
- StudyID: 2023-01380
- ClinicalTrials.gov: NCT06217328
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422